{"id":"NCT01835431","sponsor":"Novo Nordisk A/S","briefTitle":"A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus","officialTitle":"A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10-17","primaryCompletion":"2014-11-07","completion":"2014-11-07","firstPosted":"2013-04-19","resultsPosted":"2015-11-17","lastUpdate":"2019-06-11"},"enrollment":362,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 1"],"interventions":[{"type":"DRUG","name":"insulin degludec/insulin aspart","otherNames":[]},{"type":"DRUG","name":"insulin aspart","otherNames":[]},{"type":"DRUG","name":"insulin detemir","otherNames":[]},{"type":"DRUG","name":"insulin aspart","otherNames":[]}],"arms":[{"label":"Insulin degludec/insulin aspart","type":"EXPERIMENTAL"},{"label":"Insulin detemir","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted in Asia, Europe and North and South America. The aim of the trial is to investigate the efficacy and safety of insulin degludec/insulin aspart once daily plus insulin aspart for the remaining meals in children and adolescents with type 1 diabetes mellitus.","primaryOutcome":{"measure":"Change From Baseline in HbA1c (Glycosylated Haemoglobin) (%)","timeFrame":"Week 0 to week 16","effectByArm":[{"arm":"IDegAsp OD","deltaMin":-0.3,"sd":1},{"arm":"IDet OD/BID","deltaMin":-0.3,"sd":0.9}],"pValues":[]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":73,"countries":["United States","Belgium","Brazil","Canada","Croatia","Czechia","India","Israel","North Macedonia","Poland","Russia","Serbia","Slovenia","South Africa","Spain"]},"refs":{"pmids":["30666772","30014589"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":181},"commonTop":["Nasopharyngitis","Headache","Vomiting","Abdominal pain upper","Upper respiratory tract infection"]}}